Immunoglobulin E levels and risk of lymphoma in a case-control study in Spain

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 7, 2007, Pages 1492-1498

  Ellison Loschmann, Lis ^a,d   Benavente, Yolanda ^a   Douwes, Jeroen ^d   Buendia, Enric ^b   Font, Rebecca ^a   Álvaro, Tomás ^e   Kogevinas, Manolis ^c,f   De Sanjosé, Silvia ^a  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^d MASSEY UNIVERSITY   (New Zealand)

^e HOSPITAL VERGE DE LA CINTA   (Spain)

^f UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ARTICLE; ASTHMA; ATOPY; BLOOD ANALYSIS; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROL GROUP; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ECZEMA; FEMALE; HISTOLOGY; HOSPITAL; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; INTERVIEW; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING; SPAIN; WORLD HEALTH ORGANIZATION;

CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN E; LYMPHOMA; MALE; MIDDLE AGED; RISK FACTORS; SPAIN;

EID: 34447506122     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0176     Document Type: Article

References (46)

1. Tavani A, La Vecchia C, Franceschi S, Serraino D, Carbone A. Medical history and risk of Hodgkin and non-Hodgkin lymphoma. Eur J Cancer Prev 2000;9:59-64.
2. Grulich AE, Vajdic CM, Kaldor JM, et al. Birth order, atopy and risk of non-Hodgkin lymphoma. J Natl Cancer Inst 2005;97:587-94.
3. Fabbro-Peray P, Daures J-P, Rossi J-F. Environmental risk factors for non-Hodgkin's lymphoma: a population-based case-control study in Languedoc-Roussillon, France. Cancer Causes Control 2001;12:201-12.
4. Holly EA, Lele C, Bracci PM, McGrath MS. Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay area, California. Am J Epidemiol 1999;150:375-89.
5. Mills PK, Beeson WL, Fraser GE, Philips RL. Allergy and cancer: organ site-specific results from the Adventist Health study. Am J Epidemiol 1992;136:287-95.
6. Zhang Y, Holford TR, Leaderer B, et al. Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women. Cancer Causes Control 2004;15:419-28.
7. Turner MC, Chen Y, Krewski D, Ghadirian P, Thun MJ, Calle EE. Cancer mortality among US men and women with asthma and hay fever. Am J Epidemiol 2005;162:212-21.
8. Soderberg KC, Jonsson F, Wingvist O, Hagmar L, Feychting M. Autoimmune diseases, asthma and risk of haematological malignancies: a nationwide case-control study. Eur J Cancer 2006;42:3028-33.
9. Melbye M, Ekstrom-Smedby K, Lehtinen T, et al. Atopy and risk of non-Hodgkin lymphoma. J Natl Cancer Inst 2007;99:158-66.
10. McCormick DP, Ammann AJ, Ishizaka K, Miller DG, Hong R. A study of allergy in patients with malignant lymphoma and chronic lymphocytic leukaemia. Cancer 1971;27:93-9.
11. Lindelof B, Granath F, Tengvall-Linder M, Ekbom A. Allergy and cancer. Allergy 2005;60:1116-20.
12. Eriksson NE, Mikoczy Z, Hagmar L. Cancer incidence in 13811 patients skin tested for allergy. J Investig Allergol Clin Immunol 2005;15:161-6.
13. Thomas MR, Steinberg P, Votaw ML, Calaresu FR. IgE levels in Hodgkin's disease. Ann Allergy 1976;37:416-9.
14. Amlot PL, Green LA. Atopy and immunoglobulin E concentrations in Hodgkin's disease and other lymphomas. Br Med J 1978;1:327-9.
15. Rubinstein E, Sokal JR, Reisman RE, Arbesman C. Relationship of serum total IgE and cell mediated immunity in patients with Hodgkin's disease. Int Arch Allergy Appl Immunol 1977;55:439-43.
16. von Wasielewski R, Seth S, Franklin J, et al. Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors. Blood 2000;95:1207-13.
17. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153-6.
18. Rosenbaum JT, Dwyer JM. The role of IgE in the immune response to neoplasia: a review. Cancer 1977;39:11-20.
19. Skinnider BF, Mak TW. The role of cytokines in classical Hodgkin lymphoma. Blood 2002;99:4283-97.
20. Mori T, Takada R, Watanabe R, Okamoto S, Ikeda Y. T-helper (Th)1/Th2 imbalance in patients with previously untreated B cell diffuse large cell lymphoma. Cancer Immunol Immunother 2001;50:566-8.
21. Becker N, Deeg E, Nieters A. Population-based study of lymphoma in Germany: rationale, study design and first results. Leuk Res 2004;28:713-24.
22. Douwes J, Gibson P, Pekkanen J, Pearce N. Non-eosinophilic asthma: importance and possible mechanisms. Thorax 2002;57:643-8.
23. Wang H, Diepgen TL. Is atopy a protective or a risk factor for cancer? A review of epidemiological studies. Allergy 2005;60:1098-111.
24. Turner MC, Chen Y, Krewski D, Ghadirian P. An overview of the association between allergy and cancer. Int J Cancer 2006;118:3124-32.
25. Kogevinas M, Zock J-P, Alvaro T, et al. Occupational exposure to immunologically active agents and risk for lymphoma. Cancer Epidemiol Biomarkers Prev 2004;13:1814-8.
26. de Sanjosé S, Nieters A, Goedert JJ, et al. Role of hepatitis virus infection in malignant lymphoma in Spain. Int J Cancer 2004;111:81-5.
27. Talbot-Smith A, Fritschi L, Divitini ML, Mallon DF, Knuiman MW. Allergy, atopy and cancer: a prospective study of the 1981 Busselton cohort. Am J Epidemiol 2003;157:606-12.
28. Eckschlager T, Prusa R, Hladikova M, Radvanska J, Slaby K, Radvansky J. Lymphocyte subpopulations and immunoglobulin levels in Hodgkin's disease survivors. Neoplasma 2004;51:261-4.
29. Ito A, Strober W, Broder S, Plomar SH, Waldmann TA. The metabolism of IgE in patients with immunodeficiency states and neoplastic conditions. J Clin Invest 1977;59:743-55.
30. Munitz A, Levi-Schaffer F. Eosinphils: "new" roles for "old" cells. Allergy 2004;59:268-75.
31. Bosetti C, Talamini R, Franceschi S, Negri E, Giacosa A, La Vechchia C. Allergy and the risk of selected digestive and laryngeal neoplasms. Eur J Cancer Prev 2004;13:173-6.
32. Kune GA, Kune S, Watson LF. Colorectal cancer risk, chronic illnesses, operations and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res 1988;48:4399-404.
33. Wang H, Rothenbacher D, Low M, Stegmaier C, Brenner H, Diepgen TL. Atopic diseases, immunoglobulin E and risk of cancer of the prostate, breast, lung and colorectum. Int J Cancer 2006;119:695-701.
34. Strachan DP. Hay fever, hygiene and household size. BMJ 1989;299:1259-60.
35. Douwes J, Pearce N. Asthma and the Westernisation "package". Int J Epidemiol 2002;31:1098-102.
36. Becker N, de Sanjose S, Nieters A, et al. Birth order, allergies and lymphoma risk: results of the European collaborative research project EPILYMPH. Leuk Res. In press 2007.
37. Hansen DA, Robbins BA, Bylund DJ, Piro LD, Saven A, Ellison DJ. Identification of monoclonal immunoglobulins and quantitative immunoglobulin abnormalities in hairy cell leukemia and chronic lymphocytic leukemia. Am J Clin Pathol 1994;102:580-5.
38. Talpur R, Lifshitz O, Breuer-McHam J, Duvic M. Increased serum immunoglobulin levels are common in mycosis fungoides and Sézary syndrome. J Am Acad Dermatol 2002;47:685-91.
39. Rozman C, Montserrat E, Vinolas N. Serum immunoglobulin levels in B-chronic lymphocytic leukemia: natural history and prognostic significance. Cancer 1988;61:279-83.
40. Karmaus W, Arshad SH, Sadeghnejad A, Twiselton R. Does maternal immunoglobulin E decrease with increasing order of live offspring? Investigation into maternal immune tolerance. Clin Exp Allergy 2004;34:853-9.
41. Amoudruz P, Minang JT, Sundstrom Y, et al. Pregnancy, but not the allergic status, influences spontaneous and induced interleukin-1β (IL-1β), IL-6, IL-10 and IL-12 responses. Immunology 2006;119:18-26.
42. Monteiro RC, Hostoffer RW, Cooper MD, Bonner JR, Gartland GL, Kubagawa H. Definition of immunoglobulin A receptors on eosinophils and their enhanced expression in allergic individuals. J Clin Invest 1993;92:1681-5.
43. Ellison-Loschmann L, Sunyer J, Plana E, et al. Socioeconomic status, asthma and chronic bronchitis in a large community-based study. Eur Resp J 2007;29:1-9.
44. Barbee RA, Halonen M, Kaltenborn W, Lebowitz M, Burrows B. A longitudinal study of serum IgE in a community cohort: correlations with age, sex, smoking, and atopic status. J Allergy Clin Immunol 1987;79:919-27.
45. Waldmann TA, Bull JM, Bruce RM, et al. Serum immunoglobulins E levels in patients with neoplastic disease. J Immunol 1974;113:379-86.
46. Grieco MH. Immunoglobulins and hypersensitivity in human immunodeficiency virus (HIV) infection. J Allergy Clin Immunol 1989;84:11.